作为协议的一部分，葛兰素史克不承认存在不当行为，并在一份声明中表示，“没有一致或可靠的证据”表明该药的活性成分雷尼替丁(ranitidine ...
and independent laboratories shows that one ranitidine 300 mg tablet can contain tens of thousands of nanograms (ng) of NDMA, greatly exceeding the FDA’s daily acceptable intake limit of 96 ng ...
The brand of this medicine does not contain ranitidine, a medicine that was withdrawn from market in the United States. Zantac 360 Famotidine may also be used for purposes not listed in this ...
The FDA banned sales of ranitidine in 2020 over possible contamination with the suspected carcinogen N-nitrosodimethylamine (NDMA. Some manufacturers of the drug voluntarily suspended sales in ...
GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...
WJET Erie on MSN1 个月
Drugmaker to settle nearly 80,000 Zantac lawsuits for up to $2.2 billion(WJET/WFXP) — UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 ...
Reuters on MSN1 个月
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion(Reuters) -GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued ...
Ranitidine Tablets USP 150 mg, Ranitidine Tablets USP 300 mg, Ciprofloxacin Tablets USP 250 mg, Ciprofloxacin Tablets USP 500 mg, Atorvastatin Tablets USP 10mg, Sildenafil citrate Tablets BP 100 ...
GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen.
在大会上，谷玉坤先生为大家展现了坦克品牌的辉煌历程和卓越成就。谷玉坤先生表示：“从坦克300上市开始，坦克就一直是用户喜欢的越野品牌，产品款款经典，个个能打，销量连续38个月，位居中国硬派越野销量榜首，市占率始终在50%以上。在中国，每卖两 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈